Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Conference Coverage

Conference Coverage
Treat-to-Target Tapering of TNFi Studied for Noninferiority in PsA, axSpA
01/03/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Patients with psoriatic arthritis and axial spondyloarthritis may be able to safely taper tumor necrosis factor inhibitors using a treat-to-target approach, new research indicates.
Patients with psoriatic arthritis and axial spondyloarthritis may be able to safely taper tumor necrosis factor inhibitors using a treat-to-target approach, new research indicates.
Patients with psoriatic...
01/03/2024
Rheumatology & Arthritis
Conference Coverage
Victoria Konzett, MD, on RA Flares Based on SDAI and CDAI
12/27/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
During her presentation on diagnosis, manifestations, and outcomes of rheumatoid arthritis (RA), Dr Victoria Konzett defined RA flares based on SDAI and CDAI.
During her presentation on diagnosis, manifestations, and outcomes of rheumatoid arthritis (RA), Dr Victoria Konzett defined RA flares based on SDAI and CDAI.
During her presentation on...
12/27/2023
Rheumatology & Arthritis
Conference Coverage
Dr Peter Taylor on Effectiveness of Upadacitinib in RA Pain Management
12/26/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Patients with rheumatoid arthritis generally consider pain to be the highest priority domain compared to any other symptoms.
Patients with rheumatoid arthritis generally consider pain to be the highest priority domain compared to any other symptoms.
Patients with rheumatoid...
12/26/2023
Rheumatology & Arthritis

Advertisement

Conference Coverage
Gregory McDermott, MD: Predictors of RA-ILD and Subtypes
12/26/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Several factors have been shown to be associated with increased risk of rheumatoid arthritis-associated lung diseases. Dr Gregory McDermott investigates.
Several factors have been shown to be associated with increased risk of rheumatoid arthritis-associated lung diseases. Dr Gregory McDermott investigates.
Several factors have been shown...
12/26/2023
Rheumatology & Arthritis
Conference Coverage
Breakthrough COVID-19 Infection Among RA Patients After Third Dose
12/26/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
In August 2021, the CDC recommended a third SARS-CoV-2 mRNA vaccine dose to complete the initial vaccine series for immunosuppressed patients.
In August 2021, the CDC recommended a third SARS-CoV-2 mRNA vaccine dose to complete the initial vaccine series for immunosuppressed patients.
In August 2021, the CDC...
12/26/2023
Rheumatology & Arthritis
Conference Coverage
This or That? Rieke Alten, MD, Reviews Treatment Preferences for RA Patients
12/20/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Findings of an online survey revealed the trade-offs most acceptable among patients with rheumatoid arthritis when selecting treatments.
Findings of an online survey revealed the trade-offs most acceptable among patients with rheumatoid arthritis when selecting treatments.
Findings of an online survey...
12/20/2023
Rheumatology & Arthritis

Advertisement

Conference Coverage
Rheumatoid Arthritis and Long COVID—A Double Whammy
12/20/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
The increased odds of Long COVID in rheumatoid arthritis (RA)—a direct response to infection or the natural RA symptom course? Dr Kaleb Michaud explains.
The increased odds of Long COVID in rheumatoid arthritis (RA)—a direct response to infection or the natural RA symptom course? Dr Kaleb Michaud explains.
The increased odds of Long COVID...
12/20/2023
Rheumatology & Arthritis
Conference Coverage
Vibeke Strand, MD, on Results of the Phase 3 SELECT-EARLY Trial
12/12/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
The phase 3 SELECT-EARLY trial evaluated the efficacy and safety of upadacitinib monotherapy vs methotrexate monotherapy among methotrexate-naïve patients with moderately to severely active RA.
The phase 3 SELECT-EARLY trial evaluated the efficacy and safety of upadacitinib monotherapy vs methotrexate monotherapy among methotrexate-naïve patients with moderately to severely active RA.
The phase 3 SELECT-EARLY trial...
12/12/2023
Rheumatology & Arthritis
Conference Coverage
JAK Inhibitors for Psoriatic Arthritis? Results of the JAK-pot Study
12/05/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
JAK inhibitors (JAKi) have been studied for rheumatoid arthritis and ulcerative colitis. What’s the role of JAKi in the treatment of psoriatic arthritis?
JAK inhibitors (JAKi) have been studied for rheumatoid arthritis and ulcerative colitis. What’s the role of JAKi in the treatment of psoriatic arthritis?
JAK inhibitors (JAKi) have been...
12/05/2023
Rheumatology & Arthritis

Advertisement

Conference Coverage
PsA and PsO Affecting Work Productivity?
11/20/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Dr Nancy Shadick explains the disease burden of psoriatic arthritis and psoriasis that interferes with a patient’s worklife.
Dr Nancy Shadick explains the disease burden of psoriatic arthritis and psoriasis that interferes with a patient’s worklife.
Dr Nancy Shadick explains the...
11/20/2023
Rheumatology & Arthritis

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Popular Articles

News
Researchers Identify Association Between Lupus Nephritis and Low Bone Mineral Density
02/05/2021
The authors compared baseline characteristics of persons with juvenile-onset systemic lupus erythematosus (SLE) with and without lupus nephritis to identify clinical and laboratory predictors of lupus nephritis in SLE.
The authors compared baseline characteristics of persons with juvenile-onset systemic lupus erythematosus (SLE) with and without lupus nephritis to identify clinical and laboratory predictors of lupus nephritis in SLE.
The authors compared baseline...
02/05/2021
Autoimmune
News
An Overview of Behçet Disease
12/10/2020
Behçet disease, also known as Behçet syndrome, is rare in the United States. Delfin Santos, MD, discusses important clinical considerations and characteristics of this condition.
Behçet disease, also known as Behçet syndrome, is rare in the United States. Delfin Santos, MD, discusses important clinical considerations and characteristics of this condition.
Behçet disease, also known as...
12/10/2020
Autoimmune
News
Certain PsA Treatment Targets Are Linked To Vascular Benefits
10/20/2020
Because the association was uncertain, researchers assessed the vascular effects of achieving treatment targets such as the PsA Disease Activity Score and the Disease Activity in PsA score. The analysis shed some light on the association.
Because the association was uncertain, researchers assessed the vascular effects of achieving treatment targets such as the PsA Disease Activity Score and the Disease Activity in PsA score. The analysis shed some light on the association.
Because the association was...
10/20/2020
Autoimmune
5 Questions About Patients With STAT3 LOF and Lupus-Like Autoimmunity
Q&As
5 Questions About Patients With STAT3 LOF and Lupus-Like Autoimmunity
09/03/2020
NIH researchers have identified a cohort of patients with STAT3 LOF who have systemic lupus erythematosus-like autoimmunity with predominant renal involvement. In this Q&A, Sarthak Gupta, MD, provides insight into this patient population.
NIH researchers have identified a cohort of patients with STAT3 LOF who have systemic lupus erythematosus-like autoimmunity with predominant renal involvement. In this Q&A, Sarthak Gupta, MD, provides insight into this patient population.
NIH researchers have identified...
09/03/2020
Autoimmune
News
Gluten-Free Diet Improves Quality of Life in Celiac Disease
07/21/2020
Findings from a recent study showed patients with nonclassical and classical presentations of celiac disease benefited from a gluten-free diet.
Findings from a recent study showed patients with nonclassical and classical presentations of celiac disease benefited from a gluten-free diet.
Findings from a recent study...
07/21/2020
Autoimmune

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Stay In the Know

Autoimmune Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use